Literature DB >> 26902479

Female genital alteration: a compromise solution.

Kavita Shah Arora1, Allan J Jacobs2.   

Abstract

Despite 30 years of advocacy, the prevalence of non-therapeutic female genital alteration (FGA) in minors is stable in many countries. Educational efforts have minimally changed the prevalence of this procedure in regions where it has been widely practiced. In order to better protect female children from the serious and long-term harms of some types of non-therapeutic FGA, we must adopt a more nuanced position that acknowledges a wide spectrum of procedures that alter female genitalia. We offer a revised categorisation for non-therapeutic FGA that groups procedures by effect and not by process. Acceptance of de minimis procedures that generally do not carry long-term medical risks is culturally sensitive, does not discriminate on the basis of gender, and does not violate human rights. More morbid procedures should not be performed. However, accepting de minimis non-therapeutic f FGA procedures enhances the effort of compassionate practitioners searching for a compromise position that respects cultural differences but protects the health of their patients. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Keywords:  Circumcision; Newborns and Minors; Sexuality/Gender; Surgery

Mesh:

Year:  2016        PMID: 26902479     DOI: 10.1136/medethics-2014-102375

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  10 in total

1.  Public Health Research Priorities to Address Female Genital Mutilation or Cutting in the United States.

Authors:  Holly G Atkinson; Deborah Ottenheimer; Ranit Mishori
Journal:  Am J Public Health       Date:  2019-09-19       Impact factor: 9.308

2.  Female genital mutilation: the role of medical professional organizations.

Authors:  Tony Bazi
Journal:  Int Urogynecol J       Date:  2016-11-17       Impact factor: 2.894

Review 3.  Current critiques of the WHO policy on female genital mutilation.

Authors:  Brian D Earp; Sara Johnsdotter
Journal:  Int J Impot Res       Date:  2020-05-26       Impact factor: 2.896

4.  A repeat call for complete abandonment of FGM.

Authors:  Ian Askew; Ted Chaiban; Benoit Kalasa; Purna Sen
Journal:  J Med Ethics       Date:  2016-04-08       Impact factor: 2.903

5.  Baseline data from a planned RCT on attitudes to female genital cutting after migration: when are interventions justified?

Authors:  Anna Wahlberg; Sara Johnsdotter; Katarina Ekholm Selling; Carina Källestål; Birgitta Essén
Journal:  BMJ Open       Date:  2017-08-11       Impact factor: 2.692

6.  Thirty-year trends in the prevalence and severity of female genital mutilation: a comparison of 22 countries.

Authors:  Alissa Koski; Jody Heymann
Journal:  BMJ Glob Health       Date:  2017-11-25

7.  Factors associated with the support of pricking (female genital cutting type IV) among Somali immigrants - a cross-sectional study in Sweden.

Authors:  Anna Wahlberg; Sara Johnsdotter; Katarina Ekholm Selling; Carina Källestål; Birgitta Essén
Journal:  Reprod Health       Date:  2017-08-08       Impact factor: 3.223

8.  Female genital cutting in Malaysia: a mixed-methods study.

Authors:  Abdul Rashid; Yufu Iguchi
Journal:  BMJ Open       Date:  2019-04-01       Impact factor: 2.692

Review 9.  Medicalized Female Genital Mutilation/Cutting: Contentious Practices and Persistent Debates.

Authors:  Samuel Kimani; Bettina Shell-Duncan
Journal:  Curr Sex Health Rep       Date:  2018-02-21

10.  A Spatial Analysis of the Prevalence of Female Genital Mutilation/Cutting among 0-14-Year-Old Girls in Kenya.

Authors:  Ngianga-Bakwin Kandala; Chibuzor Christopher Nnanatu; Glory Atilola; Paul Komba; Lubanzadio Mavatikua; Zhuzhi Moore; Gerry Mackie; Bettina Shell-Duncan
Journal:  Int J Environ Res Public Health       Date:  2019-10-28       Impact factor: 3.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.